In a recent study, BMP9 was shown to be a sensitive and specific biomarker of porto-pulmonary hypertension patients in order to predict transplant-free survival and the presence of PAH in liver disease [125]. The gene discussed is GDF2; the disease is pulmonary arterial hypertension.